Skip To Content
JEWISH. INDEPENDENT. NONPROFIT.
Breaking News

Ben Stiller Opens Up on Prostate Cancer Fight

Actor and comedian Ben Stiller revealed that he was diagnosed with prostate cancer two years ago.

Due to early detection Stiller, 50, was able to undergo treatment for the disease and has been cancer-free since, he said in an interview on for SiriusXM’s The Howard Stern Show on Tuesday. He published an essay about his ordeal on medium.com that appeared online during the Stern interview.

He credited an early screening for Prostate-Specific Antigen, or PSA, for his good result. His doctor had ordered the baseline test for Stiller when he was 46, despite the fact that Stiller did not have a family history of the disease and was not officially in a high risk category. When the PSA numbers rose over two years, the doctor ordered more invasive tests which identified the cancer.

“It came out of the blue for me,” Stiller told Stern. “The one thing that it does is it just stops everything in your life when you get a diagnosis of cancer, because you can’t plan for a movie, because you don’t know what’s going to happen.”

The American Cancer Society recommends men discuss the test with their doctor when they reach 50.

In his Medium essay, Stiller calls for the test to be administered as early as age 40 if the patient requests it.

“Taking the PSA test saved my life. Literally. That’s why I am writing this now,” Stiller said in the essay.

“The bottom line for me: I was lucky enough to have a doctor who gave me what they call a “baseline” PSA test when I was about 46. I have no history of prostate cancer in my family and I am not in the high-risk group, being neither — to the best of my knowledge — of African or Scandinavian ancestry. I had no symptoms.

“What I had — and I’m healthy today because of it — was a thoughtful internist who felt like I was around the age to start checking my PSA level, and discussed it with me.”

A message from our CEO & publisher Rachel Fishman Feddersen

I hope you appreciated this article. Before you go, I’d like to ask you to please support the Forward’s award-winning, nonprofit journalism during this critical time.

At a time when other newsrooms are closing or cutting back, the Forward has removed its paywall and invested additional resources to report on the ground from Israel and around the U.S. on the impact of the war, rising antisemitism and polarized discourse.

Readers like you make it all possible. Support our work by becoming a Forward Member and connect with our journalism and your community.

—  Rachel Fishman Feddersen, Publisher and CEO

Join our mission to tell the Jewish story fully and fairly.

Republish This Story

Please read before republishing

We’re happy to make this story available to republish for free, unless it originated with JTA, Haaretz or another publication (as indicated on the article) and as long as you follow our guidelines. You must credit the Forward, retain our pixel and preserve our canonical link in Google search.  See our full guidelines for more information, and this guide for detail about canonical URLs.

To republish, copy the HTML by clicking on the yellow button to the right; it includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to the Forward. It does not include images; to avoid copyright violations, you must add them manually, following our guidelines. Please email us at editorial@forward.com, subject line “republish,” with any questions or to let us know what stories you’re picking up.

We don't support Internet Explorer

Please use Chrome, Safari, Firefox, or Edge to view this site.

Exit mobile version